TrialRadiation oncology (London, England)2015

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer.

Gang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.